Societatea Nationala de Gaze Naturale Romgaz SA (SNG)
Bucharest Stock Exchange · Romania · prices in RON · close of 22 Oct 2026
Key indicators
| Last close | RON 18.96 |
|---|---|
| 52-week range | 8.98 – 20.50 |
| Return, 1 month / 3 months | +23.6% / +3.6% |
| Return, 1 year / 3 years | +107.9% / +344.5% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 31.1% |
| Worst drawdown (1 year) | -23.8% |
| Average daily value traded | 11.33M RON |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Societatea Nationala de Gaze Naturale Romgaz is a Romanian natural gas company based in Medias. It explores for and produces natural gas from onshore fields, mainly in the Transylvania region, and supplies the fuel to industrial users, gas distributors and households across Romania. The company also runs underground gas storage facilities that help balance seasonal demand. Its business centres on extracting and delivering gas rather than refining or retailing other energy products.
The shares are listed on the Bucharest Stock Exchange in Romania under the code SNG, and the price on this page is in Romanian lei (RON). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Societatea Nationala de Gaze Naturale Romgaz SA (SNG) trades on the Bucharest Stock Exchange in Romania. It last closed at RON 18.96 on 22 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 3 of 122 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 107.9% and over the last three months it rose 3.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bucharest Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 31.4% | ||
| From 52-week high | -5.0% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 3.6% | ||
| 6-month return | 53.9% | ||
| 12-month return, skipping the last month | 68.2% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.8% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 11.33M RON | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +23.6% |
| 3 months | +3.6% |
| 6 months | +53.9% |
| 1 year | +107.9% |
| 3 years | +344.5% |
| 5 years | +536.2% |
Signals
| 50-day / 200-day average | 17.55 / 14.43 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2026 | RON 0.1572 |
| 3 Jul 2025 | RON 0.1568 |
| 4 Jul 2024 | RON 0.1425 |
| 5 Jul 2023 | RON 3.4200 |
| 5 Jul 2022 | RON 3.8000 |
| 7 Jun 2021 | RON 1.7900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bucharest Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.